Champions Onco…
ProfileJobs

Champions Oncology

Suggest Edit
    • Healthdrug developmentoncologyplatform

    Champions Oncology develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The Company provides Personalized Oncology Solutions that assist physicians in developing personalized treatment options for cancer patients through tumor specific data obtained from drug panels and related personalized oncology services.

    Revenue(FY, 2016)
    $11.2 M
    Market capitalization(2018-06-14)
    $65.3 M
    Type
    Public
    HQ
    Hackensack, US
    Founded
    2007
    Size (employees)
    79 (est)+32%
    Website
    championsoncology.com
    Champions Oncology was founded in 2007 and is headquartered in Hackensack, US
    Report incorrect company information

    Key People/Management at Champions Oncology

    Ronnie Morris

    Ronnie Morris

    CEO
    Angela Davies

    Angela Davies

    Chief Medical Officer

    Champions Oncology Office Locations

    Champions Oncology has offices in Hackensack, Baltimore and London
    Hackensack, US (HQ)
    307 1 University Plaza Dr
    Baltimore, US
    602 855 N Wolfe St
    London, GB
    2 Royal College St
    Show all (3)
    Report incorrect company information

    Champions Oncology Financials and Metrics

    Champions Oncology Financials

    Champions Oncology's revenue was reported to be $11.18 m in FY, 2016 which is a 26.2% increase from the previous period.
    USD

    Revenue (Q3, 2018)

    		15.3 m

    Net income (Q3, 2018)

    		(844 k)

    EBIT (Q3, 2018)

    		(755 k)

    Market capitalization (14-Jun-2018)

    		65.3 m

    Closing share price (14-Jun-2018)

    		5.9

    Cash (31-Jan-2018)

    		1.1 m
    Champions Oncology's current market capitalization is $65.3 m.
    Annual
    USDFY, 2014FY, 2015FY, 2016

    Revenue

    		11.6 m8.9 m11.2 m

    Revenue growth, %

    		(23%)26%

    Sales and marketing expense

    		3.4 m

    General and administrative expense

    		5.2 m
    Quarterly
    USDQ2, 2018Q3, 2018

    Revenue

    		5.2 m15.3 m

    Sales and marketing expense

    		551 k1.9 m

    General and administrative expense

    		954 k3.2 m

    R&D expense

    		1.1 m3.3 m
    show all
    Annual
    USDFY, 2014FY, 2015FY, 2016

    Cash

    		5.9 m9.4 m

    Accounts Receivable

    		1.3 m1.1 m1.3 m

    Inventories

    		383 k346 k443 k

    Current Assets

    		7.6 m10.8 m4.3 m
    Quarterly
    USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

    Cash

    		7.6 m5.8 m3.1 m575 k182 k6.8 m4.2 m3.3 m4.5 m4.3 m3.5 m430 k660 k1.1 m

    Accounts Receivable

    		1.5 m3.1 m925 k1.1 m1.1 m1.5 m1.9 m2.1 m1.6 m1.9 m2 m2.7 m2.6 m2.9 m

    Current Assets

    		9.3 m9.2 m4.4 m2.1 m1.5 m8.6 m6.3 m5.8 m6.4 m6.7 m6.1 m3.5 m3.5 m4.2 m

    PP&E

    		387 k421 k411 k395 k469 k445 k420 k514 k590 k561 k672 k2.1 m2 m2 m
    show all
    Annual
    USDFY, 2014FY, 2015FY, 2016

    Net Income

    		(7.4 m)(13.1 m)(10.4 m)

    Depreciation and Amortization

    		213 k214 k156 k

    Accounts Payable

    		(223 k)433 k482 k
    Quarterly
    USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q3, 2018

    Net Income

    		(844 k)

    Depreciation and Amortization

    		253 k

    Accounts Payable

    		1.3 m1.6 m1.4 m1.4 m1.3 m1.5 m1.5 m1.2 m1.3 m124 k

    Cash From Operating Activities

    		(1.2 m)
    show all
    USDY, 2018

    Financial Leverage

    		15 x
    Show all financial metrics
    Report incorrect company information

    Competitors

    Aeglea Biotherapeutics
    Health - Public
    Heat Biologics
    Health - Public
    XBiotech
    Health - Public
    Agios Pharmaceuticals
    Health - Public
    Compare competitors

    Champions Oncology Online and Social Media Presence

    Embed Graph
    Report incorrect company information
    Download PDF